Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00044655
What this trial is testing

Switching Medication to Treat Schizophrenia

Who this might be right for
Schizophrenia
Icahn School of Medicine at Mount Sinai 219
Not applicableStudy completedNCT02366897
What this trial is testing

Extrapyramidal Side-Effects in Antipsychotic Drug Therapeutics

Who this might be right for
Drug-induced Extrapyramidal Side Effects
University of Edinburgh 21
Testing effectiveness (Phase 2)Study completedNCT00097942
What this trial is testing

Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients

Who this might be right for
Schizophrenia
Forest Laboratories 138
Post-approval studies (Phase 4)Study completedNCT00417482
What this trial is testing

Antipsychotic Discontinuation in Alzheimer's Disease

Who this might be right for
Alzheimer DiseasePsychotic DisordersAgitation+1 more
New York State Psychiatric Institute 180
Large-scale testing (Phase 3)Study completedNCT02013622
What this trial is testing

Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 49
Large-scale testing (Phase 3)Looking for participantsNCT07363577
What this trial is testing

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

Who this might be right for
Schizophrenia
LB Pharmaceuticals Inc. 456
Not applicableStudy completedNCT00174200
What this trial is testing

Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone

Who this might be right for
SchizophreniaPsychotic Disorders
Pfizer 20
Not applicableStudy completedNCT00448630
What this trial is testing

An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics

Who this might be right for
SchizophreniaMetabolic Syndrome X
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 328
Post-approval studies (Phase 4)Study completedNCT02526030
What this trial is testing

Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up

Who this might be right for
SchizophreniaPsychotic Disorders
Fundación Marques de Valdecilla 203
Testing effectiveness (Phase 2)Study completedNCT01875822
What this trial is testing

Open-label Study of Curcumin C-3 Complex in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderDepression
Woodbury, Michel, M.D. 17
Not applicableStudy completedNCT01245348
What this trial is testing

Relative Effectiveness of Schizophrenia Therapy Study

Who this might be right for
SchizophreniaBipolar Disorder
Medco Health Solutions, Inc. 1,110
Not applicableStudy completedNCT00328952
What this trial is testing

Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia

Who this might be right for
SchizophreniaHallucinations
Seoul National University Hospital 40
Large-scale testing (Phase 3)Study completedNCT01432444
What this trial is testing

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 493
Testing effectiveness (Phase 2)Study completedNCT00816894
What this trial is testing

D-serine Monotherapy for Schizophrenia

Who this might be right for
Schizophrenia
Herzog Hospital 18
Not applicableUnknownNCT01215383
What this trial is testing

The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder
Ziv Hospital 20
Not applicableStudy completedNCT00888264
What this trial is testing

A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder

Who this might be right for
Bipolar Disorders
AstraZeneca 152
Not applicableStudy completedNCT01976793
What this trial is testing

Retrospective Observational Study DIANA Study

Who this might be right for
Major Depressive Episode
AstraZeneca 450
Not applicableLooking for participantsNCT05951660
What this trial is testing

Sex, Psychopharmacology, and Diabetes

Who this might be right for
SchizophreniaSchizophrenia Spectrum and Other Psychotic DisordersDiabetes Mellitus+4 more
Zealand University Hospital 256
Not applicableStudy completedNCT00597168
What this trial is testing

Quality of Life in Schizophrenic Patients

Who this might be right for
Schizophrenia
AstraZeneca 124
Large-scale testing (Phase 3)Study completedNCT00210717
What this trial is testing

Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 748
Next Page